You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 18, May 12, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Complementary and Alternative Medicine
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Issues in Research in Complementary and Alternative Medicine—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Cantor and Malani claim that placebo effects can be demonstrated by comparing a pair of 2-arm trials of active treatment vs placebo that have different proportions of participants randomized to receive active treatment. This is an interesting speculation; however, we are unaware of any data to support this claim or to indicate that this design is just as able, or more able, to discriminate placebo effects than would be a 3-arm trial comparing active treatment, placebo, and no treatment. Their alternative design may suggest placebo effects but still leaves open the critical question of whether either the active treatment or placebo-control is better than no treatment.

Dr Jonas and colleagues question who determines the social value of CAM research and advocate for public input. For biomedical research in general, the public's position on an approach is expressed through participation on institutional review boards, data and safety monitoring . . . [Full Text of this Article]

Franklin G. Miller, PhD; Ezekiel J. Emanuel, MD, PhD
Department of Clinical Bioethics
National Institutes of Health

Donald L. Rosenstein, MD
Office of the Clinical Director
National Institute of Mental Health

Stephen E. Straus, MD
sstraus@nih.gov
National Center for Complementary and Alternative Medicine
National Institutes of Health
Bethesda, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ethical Issues in Research in Complementary and Alternative Medicine
Harvey E. Cantor and Anup Malani
JAMA. 2004;291(18):2192.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Wayne B. Jonas, Christine Goertz, John Ives, Ronald A. Chez, and Harald Walach
JAMA. 2004;291(18):2192.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Ted J. Kaptchuk and Anthony Lembo
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Matko Marusic
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Paul J. Millea
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues Concerning Research in Complementary and Alternative Medicine
Franklin G. Miller, Ezekiel J. Emanuel, Donald L. Rosenstein, and Stephen E. Straus
JAMA. 2004;291(5):599-604.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.